Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single‐arm, exploratory phase II trial. - Tang, Qinglian; Zhang, Xinke; Zhu, Xiaojun; Xu, Huaiyuan; Song, Guohui; Lu, Jinchang; Wu, Hao; Deng, Chuangzhong; Ai, Fei; Zhang, Yingchun; Wang, Jin (Cancer Medicine, 2024)